Centre de la douleur, pôle anesthésie-réanimation, CHU de Grenoble, Grenoble, France.
Centre de la douleur, pôle anesthésie-réanimation, CHU de Grenoble, Grenoble, France.
Brain Stimul. 2015 Jul-Aug;8(4):801-7. doi: 10.1016/j.brs.2015.01.416. Epub 2015 Feb 7.
To assess the long-term maintenance of analgesia induced by high-frequency repetitive transcranial magnetic stimulation (rTMS) of the motor cortex contralateral to pain in a naturalistic study of patients with chronic refractory facial pain.
55 patients were included (cluster headache, n = 19; trigeminal neuropathic pain, n = 21; atypical facial pain, n = 15). The rTMS protocol consisted of an "induction phase" of one daily rTMS session for five days per week during two consecutive weeks, followed by a "maintenance phase" of two sessions during one week, then one session in weeks 4 and 6, and a monthly session for the next five months. In a subset of patients, navigated targeting was performed and session duration was shortened from 20-min to 10-min (with the same number of 2000 pulses per session). The analgesic effect of rTMS was assessed on a 0-10 visual numerical scale from 15 to 180 days after treatment initiation.
All pain measures significantly decreased from baseline to D15: the intensity of permanent pain (5.2 ± 1.6 to 3.2 ± 1.9) and paroxysmal pain (8.6 ± 1.5 to 4.5 ± 3.4), as well as the daily number of painful attacks (5.6 ± 3.1 to 2.3 ± 3.1). The percentage of responders (defined as pain score decrease ≥30%) was 73% at D15 and dropped to 40% at D180. The analgesic effect was similar regardless of the type of pain and was significantly lower when session duration was shortened, irrespective of the number of pulses.
This long-term maintenance rTMS protocol can be a therapeutic option in the clinical management of patients with chronic refractory facial pain, including cluster headache. However, only part of the patients respond to this technique and session duration should not be reduced.
在一项慢性难治性面部疼痛患者的自然研究中,评估对痛侧大脑皮层进行高频重复经颅磁刺激(rTMS)诱导的镇痛的长期维持情况。
纳入 55 例患者(丛集性头痛,n=19;三叉神经病理性疼痛,n=21;非典型面痛,n=15)。rTMS 方案包括每周连续 5 天每天进行一次 rTMS 治疗的“诱导期”,随后进行为期 1 周的 2 次治疗、4 周和 6 周的 1 次治疗以及接下来 5 个月的每月 1 次治疗。在部分患者中,进行了导航靶向治疗,并将治疗时间从 20 分钟缩短至 10 分钟(每次治疗的 2000 个脉冲数相同)。在治疗开始后 15 至 180 天,采用 0-10 视觉数字评分法评估 rTMS 的镇痛效果。
所有疼痛测量指标均从基线开始显著下降至 D15:永久性疼痛强度(5.2±1.6 至 3.2±1.9)和阵发性疼痛强度(8.6±1.5 至 4.5±3.4)以及每日疼痛发作次数(5.6±3.1 至 2.3±3.1)。在 D15 时,应答率(定义为疼痛评分下降≥30%)为 73%,而在 D180 时下降至 40%。镇痛效果与疼痛类型无关,当治疗时间缩短时,无论脉冲数如何,镇痛效果均显著降低。
这种长期维持 rTMS 方案可能是慢性难治性面部疼痛患者(包括丛集性头痛)临床管理的一种治疗选择。然而,只有部分患者对该技术有反应,并且不应缩短治疗时间。